UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG)
 
UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG) 
 
Patrick Wen, Alexander Stein, Martin van den Bent, Jacques De Greve, Sascha Dietrich, Filip De Vos, Nikolas von Bubnoff, Myra van Linde, Albert Lai, Gerald Prager, Mario Campone, Angelica Fasolo, Jose Lopez-Martin, Tae Min Kim, Warren Mason, Ralf-Dieter Hofheinz, Jean-Yves Blay, Daniel Cho, Anas Gazzah, Carlos Gomez-Roca, Jeffrey Yachnin, Aislyn Boran, Paul Burgess, Ilan Palanichamy, Eduard Gasal, Vivek Subbiah
 
Abstract 

not available